| APV | DL-2-Amino-5-Phosphonopentanoic Acid |
| Ara-C | Cytosine β-D-Arabinofuranoside Hydrochloride |
| BSA/TI | Bovine Serum Albumin/Trypsin Inhibitor |
| CM+ | Conditioned Medium Plus (with FBS and supplements) |
| CM- | Conditioned Medium Minus (without FBS) |
| DAPI | 4′,6-Diamidino-2-Phenylindole |
| DIVs | Days In Vitro |
| DS | Dissection Solution |
| EDTA | Ethylenediaminetetraacetic Acid |
| FBS | Fetal Bovine Serum |
| GluN2B | Glutamate [NMDA] Receptor Subunit Epsilon-2 |
| HBSS | Hank’s Balanced Salt Solution |
| HbAA | Homozygous Humanized Mice Expressing Hemoglobin A |
| HbSS | Homozygous Humanized Sickle Cell Mice Expressing Hemoglobin S |
| HEPES | N-(2-Hydroxyethyl) Piperazine-N′-(2-Ethanesulfonic Acid) |
| HI | High Inhibitor Solution |
| LI | Low Inhibitor Solution |
| MAP2 | Microtubule-Associated Protein 2 |
| NBM/B27 | Neurobasal Medium with B27 Supplement |
| NeuN | Neuronal Nuclei Marker (RBFOX3) |
| NF200 | Neurofilament 200 kDa |
| NMDAR | N-Methyl-D-Aspartate Receptor |
| P1 | Postnatal Day 1 |
| PBS | Phosphate-Buffered Saline |
| PSD 95 | Postsynaptic Density Protein 95 |
| RT | Room Temperature |
| SCD | Sickle Cell Disease |
| TNF-α | Tumor Necrosis Factor-alpha |
| VGLUT1 | Vesicular Glutamate Transporter 1 |